Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2026-04-21 @ 1:53 PM
Study NCT ID:
NCT00813332
Status:
UNKNOWN
Last Update Posted:
2010-01-25
First Post:
2008-12-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)
Sponsor:
Simcere Pharmaceutical Co., Ltd
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
simcere002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Kai LI/Professor
Old Organization:
Cancer Hospital of Tianjin Medical University